GILEAD SCIENCES, INC. EPS (Diluted) 2007-2026 | GILD
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is GILEAD SCIENCES, INC.'s current eps (diluted)?
GILEAD SCIENCES, INC. (GILD) annual eps (diluted) for 2025 was $6.78, a 1684.21% increase from 2024. GILEAD SCIENCES, INC. eps (diluted) for the quarter ending March 31, 2026 was $1.61.
What was GILEAD SCIENCES, INC.'s eps (diluted) in 2024?
GILEAD SCIENCES, INC. annual eps (diluted) for 2024 was $0.38, a 91.56% decline from 2023.
What was GILEAD SCIENCES, INC.'s eps (diluted) in 2023?
GILEAD SCIENCES, INC. annual eps (diluted) for 2023 was $4.50, a 23.63% increase from 2022.
What is GILEAD SCIENCES, INC.'s 5-year eps (diluted) CAGR?
GILEAD SCIENCES, INC. eps (diluted) grew at a compound annual growth rate (CAGR) of 132.41% from FY2020 to FY2025, going from $0.10 to $6.78 over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.78 | +1684.2% | 10-K |
| FY2024 | $0.38 | -91.6% | 10-K |
| FY2023 | $4.50 | +23.6% | 10-K |
| FY2022 | $3.64 | -26.2% | 10-K |
| FY2021 | $4.93 | +4830.0% | 10-K |
| FY2020 | $0.10 | -97.6% | 10-K |
| FY2019 | $4.22 | +1.2% | 10-K |
| FY2018 | $4.17 | +18.8% | 10-K |
| FY2017 | $3.51 | -64.7% | 10-K |
| FY2016 | $9.94 | -16.5% | 10-K |
| FY2015 | $11.91 | +62.0% | 10-K |
| FY2014 | $7.35 | +306.1% | 10-K |
| FY2013 | $1.81 | +10.4% | 10-K |
| FY2012 | $1.64 | -7.3% | 10-K |
| FY2011 | $1.77 | +6.6% | 10-K |
| FY2010 | $1.66 | +17.7% | 10-K |
| FY2009 | $1.41 | +36.9% | 10-K |
| FY2008 | $1.03 | +25.6% | 10-K |
| FY2007 | $0.82 | - | 10-K |